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ABSTRACT An enhanced metabolic efﬁciency for
accelerating the recovery of fat mass (or catch-up fat) is
a characteristic feature of body weight regulation after
weight loss or growth retardation and is the outcome of
an “adipose-speciﬁc” suppression of thermogenesis,
i.e., a feedback control system in which signals from the
depleted adipose tissue fat stores exert a suppressive
effect on thermogenesis. Using a previously described
rat model of semistarvation-refeeding in which catch-up
fat results from suppressed thermogenesis per se, we
report here that the gene expression of stearoyl-coen-
zyme A desaturase 1 (SCD1) is elevated in skeletal
muscle after 2 wk of semistarvation and remains ele-
vated in parallel to the phase of suppressed thermogen-
esis favoring catch-up fat during refeeding. These
elevations in the SCD1 transcript are skeletal muscle
speciﬁc and are associated with elevations in microso-
mal 9 desaturase enzyme activity, in the 9 desatura-
tion index, and in the relative content of SCD1-derived
monounsaturates in several lipid fractions extracted
from skeletal muscle. An elevated skeletal muscle
SCD1, by desaturating the products of de novo lipogen-
esis and diverting them away from mitochondrial oxi-
dation, would inhibit substrate cycling between de novo
lipogenesis and lipid oxidation, thereby leading to a
state of suppressed thermogenesis that regulates the
body’s fat stores.—Mainieri, D., Summermatter, S.,
Seydoux, J., Montani, J. P., Rusconi, S., Russell, A. P.,
Boss, O., Buchala, A. J., Dulloo, A. G. A role for skeletal
muscle stearoyl-CoA desaturase 1 in control of thermo-
genesis. FASEB J. 20, E1157–E1170 (2006)
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The ability of mammals to adapt to diminished food
intake by increasing the efﬁciency of energy utilization
has been well documented from studies of prolonged
starvation in humans (1–3) and laboratory rodents (4).
This capacity for energy conservation is viewed as the
outcome of regulatory processes that, in response to
the deﬁcit in energy intake, suppress thermogenesis
and hence slow the rate of weight loss and reduce the
energy cost for weight maintenance. Since processes
that enhance metabolic efﬁciency by suppressing ther-
mogenesis also occur during refeeding (5–9), with the
energy spared being directed speciﬁcally at accelerat-
ing the recovery of body fat (2, 10), i.e., for preferential
catch-up fat, it is also viewed as the outcome of a control
system that operates as a feedback loop between the
size of the adipose fat stores and thermogenesis. This
has been referred to as “adipose-speciﬁc” control of
thermogenesis, i.e., an autoregulatory feedback system
in which signal(s) from the depleted adipose fat stores
exert a suppressive effect on thermogenesis until the fat
stores are replenished (11). Such an energy conserva-
tion mechanism, which probably evolved to optimize
survival capacity in an ancestral lifestyle characterized
by periodic food shortage, is an important factor that
nowadays contributes to the relapse of obesity after
slimming and hence to the poor efﬁcacy of dietary
restriction in the management of obesity. It also con-
tributes to preferential catch-up fat associated with
insulin resistance during catch-up growth after earlier
malnutrition (12, 13), and it has been implicated in the
link between earlier growth retardation, catch-up
growth, and increased risks for type 2 diabetes and
cardiovascular disease later in life (14).
At present, our understanding of the components
that constitute this adipose-speciﬁc control of thermo-
genesis, i.e., its sensors, signals, and effector system, is
fragmentary. The demonstration in the rat that the
suppression of thermogenesis directed at catch-up fat
persists unabated during exposure to cold (15), i.e.,
under conditions of enhanced sympathetically medi-
ated thermogenesis (16), has suggested that its effector
mechanisms might be dissociated from diminished
activity of the sympathetic nervous system (SNS) and by
extension from sympathetic modulation of the uncou-
pling protein (UCP) in brown adipose tissue (UCP1).
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In contrast, because SNS activity in skeletal muscle is
mostly unresponsive to modulation by diet or to cold
exposure (17) and this tissue is a major site for energy
conservation during prolonged starvation (18), skeletal
muscle is thought to be the major effector site for this
(SNS-independent) adipose-speciﬁc control of thermo-
genesis (11). However, despite the fact that skeletal
muscle, which accounts for 30–40% of body mass in
mammals, has long been considered as a major site for
adaptive thermogenesis, the underlying effector mech-
anisms remain elusive. Earlier interest that such regu-
lated thermogenesis in skeletal muscle might involve
mitochondrial uncoupling by UCP2 or UCP3 (two
homologues of UCP1) has waned after the demonstra-
tions that they are either up-regulated or unaltered in
response to starvation and refeeding (19–22), a pattern
of expression inconsistent with a role for these UCP
homologues in the control of adaptive thermogenesis.
Within the context of this feedback loop between the
fat stores and skeletal muscle, we have conducted
studies aimed at gaining insights into the molecular-
physiological mechanisms that could constitute the
effector system that suppress thermogenesis in skeletal
muscle for the purpose of catch-up fat. To this end, we
have used a previously described rat model of semistar-
vation-refeeding (10–12) in an attempt to identify and
validate genes the altered expression of which in skel-
etal muscle during semistarvation would persist during
refeeding in parallel to the enhanced efﬁciency for
catch-up fat and to investigate the underlying neuro-
hormonal systems. The results reported here suggest
that skeletal muscle stearoyl-coenzyme A desaturase 1
(SCD1), a rate-limiting enzyme that catalyzes the syn-
thesis of monounsaturated fatty acids (MUFA), is a key
control point in the neurohormonal effector system of
the adipose-speciﬁc control of thermogenesis.
MATERIALS AND METHODS
Animals and diets
Male Sprague-Dawley rats (Elevage Janvier, France), aged 6
wk and caged singly in a temperature-controlled room
(221°C) with a 12-h light/dark cycle, were maintained on a
commercial pelleted chow diet (Kliba, Cossonay, Switzerland)
and had free access to tap water. The experiments were
conducted after a 5 day period of adaptation in rats selected
on the basis of body weight being within 5 g of the mean
body weight (215 g). Animals used in the present studies were
maintained in accordance with our institute’s regulations and
guide for the care and use of laboratory animals.
Study design
Animal model
The experiments were conducted by using a design similar to
that previously described in establishing a rat model for
studying changes in energy expenditure that occur speciﬁ-
cally for accelerating fat deposition during refeeding (10–
12), i.e., an approach that allows suppressed thermogenesis
speciﬁc for fat recovery to be studied in the absence of
confounding variables, such as body size, food intake, and
differential rates of protein gain, on energy expenditure. As
shown in Fig. 1, groups of rats are food restricted at 50% of
their spontaneous food intake for 2 wk. After this period of
semistarvation, they are refed the same chow diet at a level
equal in metabolizable energy content to the spontaneous
food intake of control rats matched for weight at the onset of
refeeding. The cardinal feature of this experimental design is
that comparisons are made between refed animals regaining
weight vs. spontaneously growing weight-matched controls,
with both groups consuming the same amount of food
energy. Under these conditions, the refed animals show an
increased rate of body fat gain, which results from their lower
energy expenditure, than in controls. A number of factors
that could theoretically contribute to this difference in ener-
Figure 1. Study design for screening and validating candidate
skeletal muscle genes implicated in adipose-speciﬁc suppres-
sion of thermogenesis using a previously described rat model
of semistarvation-refeeding in which the accelerated fat re-
covery (catch-up fat) results only from suppressed thermo-
genesis, i.e., not from confounding effects of hyperphagia or
lower lean body mass or protein mass (10–12). In this study,
energy balance and body composition measurements were
determined over 3 successive periods of 1 wk each during
course of refeeding and comparisons made with controls
matched for weight at onset of refeeding. Acceleration of fat
deposition but not that of protein deposition (i.e., preferen-
tial catch-up fat) is attributed to diminished energy expendi-
ture (suppressed thermogenesis) that lasts for2 wk. Skeletal
muscle was harvested, namely at end of 2 wk semistarvation
period, i.e., at onset of refeeding (RF-0) and after 1 wk of
refeeding (RF-7). All values are means and se. (n6); **P 
0.01; ***P  0.001.
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getics between refed and control rats (namely level of physical
activity, age, and size of organs) have been previously evalu-
ated (4, 10–12) and were shown to have little or no impact on
the difference in energy expenditure between the two groups.
Consequently, under the conditions of our refeeding studies,
the lower energy expenditure in the refed than in control rats
is explained by the energy spared as a result of a sustained
suppression of thermogenesis for the purpose of catch-up fat.
Gene search
With the use of this rat model of catch-up fat caused by
suppressed thermogenesis per se, two approaches were under-
taken in the search for genes that could be implicated in the
effector system of the adipose-speciﬁc suppression of thermo-
genesis: 1) by applying the technique of differential display
followed by microarray analysis and 2) by screening a number
of “literature” candidate genes implicated in thermogenesis
and that are expressed in skeletal muscle; these are listed in
Table 1, under “calcium cycling genes” (23, 24) and under
“candidate genes by gene manipulation technology” (25–33),
respectively. A critical feature of both these approaches was to
identify skeletal muscle genes the altered mRNA expression
of which at the end of the 2 wk semistarvation period (RF-0)
would persist in the same direction after 1 wk of controlled
refeeding (RF-7), i.e., at a time point when thermogenesis is
suppressed but also when body fat in the refed animals has
not yet exceeded that in controls (Fig. 1). In other words, this
search aimed at identifying genes that were either down-
regulated both at RF-0 and at RF-7 or up-regulated both at
RF-0 and RF-7 and the altered expression of which during
refeeding preceeded the appearance of excess adiposity and
is hence not consequential to excess fat.
Differential display
mRNA differential display was performed using the protocol
described by Brenz Verca et al. (34). Total cellular RNA was
isolated from rat hind-limb skeletal muscle at time points RF-0
and RF-7 (n6 per group) using guanidine isothiocyanate
extraction (35). Fifty micrograms of total RNA were then
treated with 20 U of RNase free-DNase (Life Technologies).
Subsequently, 0.2 g of treated RNA were used in a reverse
transcription reaction using each of the four 1-bp-anchored
3oligo(dT) primers (DPLN) and 200 U of Mo-MLV reverse
transcriptase (Promega) in 20 l volume as recommended by
the manufacturer. Two microliters of the reverse transcribed
cDNA were then used for each polymerase chain reaction
(PCR), which was performed using the same 1-bp-anchored
3oligo(dT) primer and 5 arbitrary oligos (XAp); the se-
quences of primers used are provided in Table 1. The 50 l
PCR reaction contained 10 mM Tris-HCl at pH 8.3, 50 mM
KCl, 1.5 mM MgCl, 0.01% gelatin, 2 M dNTP (except
dATP), 1 l of P32-dATP (3000 Ci/mmol), 2 M of 5
arbitrary oligo and 3 anchored dT oligo, and 0.2 l of Taq
polymerase. Parameters for PCR were as follows: 5 cycles of
denaturing at 95°C for 45 s, annealing at 40°C for 1 min, and
extension at 72°C for 1 min, then 35 cycles of denaturing at
95°C for 1 min, annealing at 62°C for 1 min, and extension at
72°C for 1 min. Two microliters of the PCR reaction mixture
were loaded on a 6% sequencing gel, and differentially
ampliﬁed PCR fragments were visualized by exposing the
dried sequencing gel to X-ray ﬁlm. Candidate PCR products
that satisﬁed the criteria in this step of our gene search, i.e.,
either up-regulated or down-regulated at both RF-0 and RF-7,
were then excised from the sequencing gel, and the DNA was
eluted by boiling the gel slice in TE buffer (10 mM Tris, pH
7.5, and 1 mM EDTA) for 10 min. The eluted DNA fragment
was reampliﬁed by using the BT7 and XSP6 and subsequently
cloned into the TA cloning vector (Invitrogen). Five transfor-
mants for each clone were sequenced (Rexagene), and the
analysis of these data revealed 86 transcribed sequence. After
cDNA microarray analysis (Memorec), the mRNA levels of
genes of interest (selected on the basis of a change in mRNA
level 	25% at both RF-0 and RF-7 relative to respective
control) were subsequently analyzed by real-time PCR.
Semiquantitative real time-PCR
Target cDNA levels were analyzed by semiquantitative real
time (Q-RT)-PCR reaction in a buffer containing 10 mM
Tris-HCl pH 8.4, 25 mM KCl, 0.1 mM each dNTP, 0.025 U
iTaq, 1.5 mM MgCl2, SYBR Green I, and 5 nM ﬂuorescein (iQ
SYBR Green Supermix Bio-Rad). All the genes were ampliﬁed
under the same conditions: 3 min 95° for 1 cycle, 10 s 95° and
45 s 62° for 40 cycles, 1
 1 min 95°, and 1 min 55° for 1 cycle,
after which a melting curve was obtained (80
0.5 degrees
increments, 10 s, from 55–95°C). The cDNA reactions were
diluted ﬁve times, and 4 l were used for the Q-RT-PCR.
Q-RT-PCR was used to measure the mRNA levels of genes
selected from differential display/microarray analysis and the
literature candidate genes; the sequences of primers used are
provided in Table 1. All the cDNA were normalized against
cyclophilin, a housekeeping gene the expression of which did
not alter under our experimental conditions.
Preparation of microsomal fractions and assay of 9
desaturase activity (SCD)
The extraction of microsomes from skeletal muscle and
subsequent assay for microsomal SCD activity were performed
according the method described by Houdali et al. (36).
Aliquots of excised muscles were weighed (200 mg) and
ground in a liquid nitrogen-cooled porcelain mortar, and
powdered muscles were suspended in 1 ml ice-cold buffer
containing 10 mmol/l Tris, pH 7.4, 1 mmol/l dithiothreitol
and 0.25 mol/l sucrose. Further homogenization was done
with a motor-driven Potter-Elvehjem Teﬂon-glass tissue
grinder at a setting 1500 rpm and for 10 cycles. Crude
muscle homogenate was then spun at 15,000 g for 20 min,
after which the supernatant was spun in an ultracentrifuge at
100,000 g for 1 h at 4°C. After the remaining supernatant was
discarded, the microsomal fraction was resuspended in 200 l
of 0.1 mol/l sodium phosphate buffer, pH 7.4; all steps were
carried out at 4°C. The protein concentration was then
measured using the dye-based Bradford assay (Bio-Rad-Kit)
and 9 desaturase (SCD) activity was measured in the micro-
somal fraction (100 l) by the generation of 3H2O from the
substrate [9,10-3H]stearoyl-coenzyme A (CoA; Biotrend
Chemicals, Cologne, Germany, speciﬁc activity: 2.2
1012
TBq/mmol). Samples were incubated at 37°C for 5 min, and
the incubation was terminated by the addition of 1.3 ml of
ethanol and spun at 15,000 g for 5 min. Residual substrate was
removed by the addition of 40 mg of Norit A, followed by
centrifugation as before, and the 3H2O produced was mea-
sured in the supernatant by liquid scintillation counting.
Fatty acid composition analysis and 9 desaturation index
Samples of 200 mg skeletal muscle were suspended in 3.8 ml
of a mixture of chloroform:methanol:water (1:2:0.8, vol./
vol.), vortexed, and left to stand for 10 min at room temper-
ature. Lipids were extracted, using the method of Bligh and
Dyer (37), by vortexing with 1 ml of chloroform and 1 ml
water, which resulted in a mixture of chloroform-methanol-
water (2:2:1.8, vol.). After centrifugation for 5 min at 4000
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rpm, the lower chloroform-containing layer was transferred
into clean glass vials using pasteur pipettes. The extracts were
redisolved in 75 l chloroform:methanol (2:1) and fraction-
ated by thin-layer chromatography using thin layer plates
coated with 0.25 mm silica gel. Plates were preconditioned by
heating at 100°C for 2 h and were developed (20–30 min)
using hexane:diethylether:acetic acid (60:40:1, vol.). The
plates were allowed to dry in air, and the separated standard
lipid fractions were sprayed with 10% copper sulfate in 8%
phosphoric acid and visualized after heating for 20 min at
180°C. Five lipid fractions, i.e., phospholipids (PL), mono-
glycerides (MG), diglycerides (DG), free fatty acids (FFA),
and triglycerides (TG) were scraped off the plates, and lipids
were eluted in methanol (PL and MG fractions) or in
chloroform (DG, FFA, and TG fractions). An internal stan-
dard (410 ng of nonadecanoic acid) was added to each
fraction and treated with 10% BF3 in methanol as described
by Morrison and Smith (38). The resulting mixtures of fatty
acid methyl esters of the separated fractions were analyzed by
gas chromatography/mass spectrometry (HP6890 coupled to
an HP 5793 MSD; Agilent, Palo Alto, CA) using a capillary
column (SP 2380; 30 m
0.25 mm, 0.2 m) with the condi-
TABLE 1. Candidate genes screened by RT-PCR, and primers utilized
Category/Gene Name Function Primers
Candidate Genes
from Differential
Display
MLC2 Isoform of the component of thick ﬁlament;
potentiates actin-myosin interaction at low Ca2
levels
Sense 5 ATCTCTGGAGCCTTCAAGGTC 3
Antisense 5 ACATCTGGAGGGAAGGCTGC 3
MLC1/3 Isoform of the component of thick ﬁlament;
potentiates actin-myosin interaction at low Ca2
levels
Sense 5 TGAACCGTCCAATCCAGCCG 3
Anti-sense 5 TGGAAGAGCAGTGGTGGCTC 3
MHC IIX/D Isoform of the component of thick ﬁlament;
present in the fast ﬁbers
Sense 5 TACTTACCAGACAGAAGAAGACC 3
Anti-sense 5 AGCTCATGCTGCAGCTTGCG 3
MHC IIB Isoform of the component of thick ﬁlament;
present in the fast ﬁbers
Sense 5 ACCGCAAGAACGTTCTCAGGC 3
Anti-sense 5 TGCGGAACTTGGCCAGGTTG 3
Troponin C Member of the troponin complex; present in slow
and fast ﬁbers
Sense 5 TAAGAACAACGATGGCCGCATTGAC 3
Anti-sense 5 GGACCTGCAGTCTGGATGAACACG 3
Actin  Cytoskeletal house keeping gene Sense 5 AGCGTGGCTACACGTTCACCAC 5
Anti-sense 5 AGTGATGACCTGACCGTCAGGC 3
ColA1 A member of group I collagen Sense 5 TAGCCACAGCTGACACAAGACC 3
Anti-sense 5 AAGCTGTGGCCTGGGTCTTCTTG 3
MEG3/GTL2 Imprinted untranslated gene Sense 5 AGGACTCCACATCCTTACGTTGC 3
Anti-sense 5 ATTTACAGTTGGAAGGTCCTATGGG 3
Calcium Cycling
Genes
SERCA 1 Sarcoplasmic reticulum ATPase Ca2 dependent,
regulate Ca2 concentration in muscle; thyroid
hormone dependent
Sense 5 TTCCCTTCAGCAACCTGCTCTC 3
Anti-sense 5 AGTCAGCTAGTTGCCTTGTCCC 3
SERCA 2a Sarcoplasmic reticulum ATPase Ca2 dependent,
regulate Ca2 concentration in muscle; thyroid
hormone dependent
Sense 5 AGTCATTAACAGTCCTAACTGTGG 3
Anti-sense 5 TGTGTTGCTAACAACGCACATGC 3
Sarcolipin Regulates SERCA; implicated in calcium slippage
and leak
Sense 5 TCCTGGAGTTCTCACCCAGACC 3
Anti-sense 5 ACATGAGGAGCACAGTGATCAGG 3
Candidate Genes by
Gene
Manipulation
PGC-1 Nuclear receptor coactivator linked to
mitochondrial biogenesis
Sense 5 TGAAAGGGCCAAGCAGAGAGAGAGG 3
Anti-sense 5 CGCAGATTTACGGTGCATTCCTCAA 3
Mitofusin 2 Participates in mitochondrial fusion, cell respiration
and mitochondrial proton leak
Sense 5 ACCTGAATCGGCACAGAGGAG 3
Anti-sense 5 TGGAGTTGCATCGAGAAAAGAGC 3
IL6 Regulates body composition. IL6 / develop
obesity
Sense 5 ACAGAGGATACCACCCACAACAG 3
Anti-sense 5 TGCATCATCGCTGTTCATACAATC 3
Nur77 Nuclear receptor superfamily; regulates lipolysis in
skeletal muscle cells; linked to -adrenergic
receptor
Sense 5 AGCTGTGGGCTCAGCTGTAG 3
Anti-sense 5 TCTGAGTGGTGGAGCAGTCC 3
DGAT1 Involved in last step for triglycerides synthesis. Sense 5 ACAAAGACCGGCAGACCAGCG 3
DGAT/ are resistant to obesity Anti-sense 5 ACGGTAATTGCTGAAACCGCTG 3
SCD1 First-step desaturation of fatty acids; SCD1 / are
resistant to obesity
Sense 5 TGG GAA AGT GAA GCG AGC AAC CG 3
Anti-sense 5 AGA GGG GCA CCT TCT TCA TCT
TCT C 3
Leptin Regulates body weight, in part via thermogenesis;
act in CNS and peripheral tissue; deﬁciency
causes obesity
Sense 5 GTTGGACCTTAGCCCTGAATGC 3
Anti-sense 5 GAGCCAAGGTTTCTTCCCTCAA 3
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tions described in the Supelco Bulletin 855B (Supelco, Belle-
fonte, PA). Fatty acid methyl esters were identiﬁed by refer-
ence to a mass spectral (electron impact) databank and by
their retention times. Quantitation was performed by integra-
tion of the peaks in the total ion curve (ms/z 50–800 amu).
With the use of the quantitated values for palmitate (C16:0),
palmitoleate (C16:1), stearate (C18:0), and oleate (C18:1),
the desaturation index was determined by calculating the
product:substrate ratio (16:1/16:0 and 18:1/18:0).
Intramyocellular lipids
The content of neutral lipids in skeletal muscle myocytes was
determined using an oil red O (ORO) stain, as described by
Russell et al. (39). In brief, tibialis anterior muscle sections
were incubated in formalin for 10 min and washed 3 
 30 s
in deionized water before being stained for 7 min. with the
ORO solution. After being washed again for 3 
 30 s, the
sections were counterstained with Harris’s hematoxylin for 4
min and then rinsed under running tap water for 3 min. The
sections were covered with a coverslip and viewed using a
Zeiss Axiophot I microscope mounted with an Axiocam color
CCD camera. The intramyocellular neutral lipids were quan-
tiﬁed using the Zeiss KS400 V3.0 program. Approximately
420  160 ﬁbers were scanned per muscle.
Determination of energy balance and body composition
Energy balance measurements were conducted during
refeeding, as described previously (10, 12), by the compara-
tive carcass technique over periods during which ME intake
was monitored continuously. Energy expenditure was deter-
mined as the difference between energy gain and ME intake.
After the animals were killed by decapitation, the skull,
thorax, and abdominal cavity were incised and the gut
cleaned of undigested food. The whole carcasses were dried
to a constant weight in an oven maintained at 70°C and were
subsequently homogenized. Triplicate samples of the homog-
enized carcass were analyzed for energy content by bomb
calorimetry and for fat content by the Soxhlet extraction
method, as described previously (10, 12). Body protein was
determined from a general formula relating energy derived
from fat, total energy value of the carcass, and energy derived
from protein (10); the caloric values for body fat and protein
were taken as 38.6 and 22.7 kJ/g, respectively.
Blood hormone assay and urinary catecholamines
On the day of blood collection, food was removed early in the
morning (8:00 a.m.), and 6–7 h later, i.e., in the postabsorp-
tive phase, blood obtained by decapitation was centrifuged
and the plasma frozen and stored at 20°C for later assays of
hormones. Plasma leptin and thyroid hormones were mea-
sured using RIA kits (Linco, St. Charles, MD). Urinary
catecholamines were assayed from urine collected from rats
housed singly in customized metabolic cages equipped with a
grid ﬂoor and a ﬁberglass funnel for urine collection; a
special separator (Lab Products, Maywood, NJ) allowed auto-
matic separation of urine and feces. The urine was collected
in presence of 1–2 ml of 2 N HCL, and samples were stored
at 20°C until assayed for catecholamines using liquid chro-
matography with electrochemical detection.
Data analysis and statistics
All data are means  se. The data were analyzed by Mann-
Whitney nonparametric test (which makes no assumption
about the normal distribution of data), and P values 0.05
were considered signiﬁcant. In cases of P values 	0.05 but
0.1 (i.e., not far from achieving statistical signiﬁcance with the
Mann-Whitney test), the data were also analyzed by Students t
test, a parametric test that assumes normal distribution and P
values 0.05 were considered signiﬁcant. The statistical treat-
ment of data was performed using the computer software
STATISTIK, version 4.0 (Analytical Software, St. Paul, MN).
RESULTS
Gene search relevant to suppressed thermogenesis
In the search for skeletal muscle genes the altered
expression of which at the end of semistarvation (RF-0)
would still persist in the same direction at 1 wk of
refeeding (RF-7), the application of mRNA differential
display, followed by cDNA microarray analysis, did not
reveal any gene the expression of which was altered by
	50% at both RF-0 and RF-7 (Supplementary Table
S1). Furthermore, among several “structural” genes
and one “unknown” gene the expressions of which
tended to be altered in the same direction by 25% at
these two time points (Supplementary Table S1), none
could be conﬁrmed by quantitative RT-PCR analysis
(Table 2) whether in the tibialis anterior (a fast-twitch
oxidative-glycolytic) muscle or in the soleus (a slow-
twitch oxidative) muscle, except maternal expressed
gene 3 (MEG3), which is also referred to as gene
trapped locus 2 (GTL2), an untranslated RNA the
speciﬁc function of which is unknown (40). The appli-
cation of RT-PCR analysis to screen “literature” candi-
date genes implicated as effectors of thermogenesis
(Table 1) also indicated that none of them showed
statistically signiﬁcant altered expression at RF-0, which
persisted in the same direction at RF-7 in both tibialis
anterior and soleus muscles, with the exception of
SCD1. As indicated in Table 2, the mRNA levels of
SCD1 in muscles from refed animals were signiﬁcantly
higher (by 2- to 4-fold) than in the respective controls
both at RF-0 and at RF-7 and both in the tibialis
anterior muscle and in the soleus muscle.
Skeletal muscle speciﬁcity in SCD1 up-regulation
To investigate whether this persistent up-regulation of
muscle SCD1 gene expression at RF-0 and RF-7 is
speciﬁc to skeletal muscle or also occurs in other
tissues/organs where SCD1 is generally highly ex-
pressed, we also measured SCD1 mRNA levels in other
muscles as well as in liver and white adipose tissues
harvested from the same animals in the above study.
The data presented in Fig. 2 indicate that unlike in
skeletal muscle, SCD1 mRNA levels in liver were mark-
edly lower than controls at RF-0 and did not exceed
those of controls at RF-7, a pattern of SCD1 expression
that was also found in the retroperitoneal adipose
tissue, though not in the epididymal adipose tissue in
which SCD1 mRNA levels were unaltered both during
semistarvation and during refeeding. Thus, the up-
regulation of SCD1 gene expression is speciﬁc for
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skeletal muscle, since it is not observed in liver and
white adipose tissue. Subsequent studies described be-
low concentrate on the tibialis anterior muscle, since
the ﬁber composition of this fast-twitch oxidative-glyco-
lytic muscle reﬂects that observed for the bulk of
skeletal muscle mass in the rat (41).
Muscle SCD1 gene up-regulation and
hormonal proﬁle
In a study designed to investigate the kinetics of altered
SCD1 gene expression during 15 days of refeeding
together with that of hormones known to stimulate
skeletal muscle thermogenesis and to repress SCD1,
namely leptin (42, 43), thyroid hormones (23, 43), and
possibly also catecholamines (16), whose second mes-
senger cAMP has been implicated in SCD1 repression
(43), we assessed the following: 1) the mRNA levels of
SCD1 in the muscle harvested from refed and control
animals killed on the last day of semistarvation (i.e., on
day 0 of refeeding) and on day 5, 10, and 15 of
refeeding; 2) the plasma concentrations of leptin and
the thyroid hormones (T3 and T4) at these same time
TABLE 2. Results of real-time PCR of the candidate genes
Tibialis Anterior Soleus
Category/Gene Name
Semistarvation
R0/C0
Refeeding
R7/C7
Semistarvation
R0/C0
Refeeding
R7/C7
Candidate Genes from Differential Display
MLC2 1.31  0.06 0.93  0.06 0.37  0.08* 0.89  0.26
MLC1/3 0.91  0.33 0.56  0.13 0.35  0.07* 1.01  0.38
MHC IIX/D 1.63  0.22* 1.15  0.18 1.28  0.81 1.67  0.87
MHC IIB 1.09  0.14 1.01  0.16 0.32  0.09* 0.80  0.27
Troponin C 1.12  0.11 1.05  0.11 0.37  0.12** 0.62  0.14
Actin  0.85  0.16 0.76  0.08 1.16  0.25 0.76  0.20
ColA1 0.54  0.10* 0.70  0.13 4.95  1.48* 1.11  0.33
MEG3 / GTL2 0.36  0.06** 0.35  0.05** 0.41  0.11* 0.28  0.06*
Calcium Cycling Genes
SERCA 1 2.21  0.53* 0.80  0.22 0.73  0.12 0.62  0.19
SERCA 2a 1.240.44 0.520.20* ND ND
Sarcolipin 0.55  0.16* 0.33  0.07* 3.48  0.89* 1.55  0.48*
Candidate Genes by Gene Manipulation
PGC-1 0.67  0.07* 1.03  0.14 1.25  0.27 1.30  0.32
Mitofusin 2 1.50  0.15 1.35  0.28 1.28  0.11 1.07  0.10
IL6 0.60  0.09 0.96  0.29 10.7  3.8** 1.65  0.41
Nur77 3.37  0.94* 0.44  0.07 2.44  0.52 0.55  0.12
DGAT1 0.64  0.18 0.81  0.14 1.07*  0.19 1.97  0.67
SCD1 3.06 1.01** 3.58 0.48** 3.40 1.39* 2.49 0.38**
Leptin 0.56  0.10* 1.01  0.08 0.91  0.21 1.59  0.27
Data are provided as fold change compared with respective controls during semistarvation or during refeeding, and are given in arbitrary
units (mean set to 1.0); ND  not detectable; *P  0.05; **P  0.01
Figure 2. Muscle-speciﬁc increases in mRNA
levels of SCD1 (normalized to that of cyclophi-
lin) after 2 wk of semistarvation in food-re-
stricted (R-0) and control (C-0) animals, as well
as after 1 wk of controled refeeding in refed
(R-7) and control (C-7) animals. All values are
means and se (n6); * P  0.05; ** P  0.01.
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points; and 3) in a parallel experiment of similar
design, urinary excretion rates of the two main cat-
echolamines (epinephrine and norepinephrine) were
measured from urine collected from each rat during
days 12–14 of semistarvation and during days 3–5, 7–9,
and 10–12 of refeeding. The results on the kinetics of
SCD1 gene expression in skeletal muscle shown in Fig.
3A indicate that SCD1 mRNA levels were signiﬁcantly
higher relative to controls at RF-0 and RF-5 (by 3-
fold) and remained higher than controls (2-fold)
until day 15. The difference between refed and controls
was still statistically signiﬁcant on day 10 but not on day
15. The data on plasma hormones shown in Fig. 3B
indicate a marked reduction in plasma leptin, T3, and
T4 at the end of semistarvation (RF-0). However,
whereas plasma leptin and plasma T4 were no longer
below control levels from day 5 of refeeding onwards,
plasma T3, by contrast, remained lower than in controls
on day 5 as well as on day 10 of refeeding. The data on
urinary catecholamines shown in Fig. 3C indicate no
signiﬁcant differences between semistarved and control
animals in urinary excretion rate of norepinephrine
and epinephrine. During refeeding, however, whereas
urinary NE excretion rate remained similar to that of
controls, that of epinephrine was found to be lower
than in controls, with the difference being signiﬁcant
during the periods of urine collection corresponding to
the ﬁrst 10 days of refeeding. Thus, whereas plasma
leptin, T4, and T3 were signiﬁcantly lower than in
controls during semistarvation, only plasma T3 and the
Figure 3. Pattern of mRNA lev-
els of SCD1 (normalized to that
of cyclophilin) in tibialis ante-
rior muscle (A), that of plasma
leptin and thyroid hormones
(B), and that of urinary cat-
echolamines (C) at end of semi-
starvation and during course of
refeeding. All values are means
and se (n6–8); *P  0.05;
**P  0.01; ***P  0.001.
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urinary epinephrine excretion rate remained lower in
refed animals than in controls during the phase of
catch-up fat due to suppressed thermogenesis.
Indices of muscle 9 desaturase activity,
intramyocellular lipids, and fatty acid composition
To determine potential effects of an elevated muscle
SCD1 gene expression on fatty acid 9 desaturation
and lipid composition, we assessed in the tibialis ante-
rior muscle of animals at the end of the semistarvation
and after 1 wk of refeeding, i.e., at time-points RF-0 and
RF-7, the following parameters 1) microsomal 9 de-
saturase (SCD) activity and intramyocellular lipid con-
tent, and 2) fatty acid composition and 9 desaturation
index (16:1/16:0 and 18:1/18:0) of muscle lipid frac-
tions.
The data on muscle SCD activity presented in Fig. 4A
indicate that, in parallel to the elevated SCD1 mRNA
levels, the enzyme activity of SCD is signiﬁcantly ele-
vated at the end of semistarvation (72%, P0.02) and
remains higher on day 7 (44%, P0.01) of refeeding.
The data on intramyocellular lipid content, presented
in Fig. 4B indicate that it is increased at the end of
semistarvation (60%, P0.5) but not on day 7 of
refeeding when it was actually lower in muscle from
refed animals than in controls (50%, P0.05).
The data in relation to monounsaturation by SCD1,
as well as the ratio of polyunsaturated to saturated fatty
acids (PUFA:SFA), are presented in Fig. 5 for semistar-
vation and in Fig. 6 for refeeding for the various lipid
fractions: PL, MG, DG, and TG fractions; the data for
fatty acid composition of the FFA fraction are not
presented, as these were below the level of correct
quantitation. The data on muscle fatty acid composi-
tion during semistarvation (Fig. 5) indicate that, com-
pared with controls, the TG fraction of muscle from
semistarved rats shows a signiﬁcantly higher ratio of
18:1/18:0, as well as in the relative percentage of C18:1
fatty acids by 2-fold (P0.01). Furthermore, the rel-
ative percentage of C16:1 is signiﬁcantly higher in the
DG fraction (30%, P0.05), while that of C18:1 is
signiﬁcantly higher in the MG fraction (13%,
P0.05). In the PL fraction, in contrast, the ratio of
16:1/16:0, as well as the relative percentages of C16:1
and C18:1, is signiﬁcantly lower during semistarvation.
These changes in the PL fraction of muscle from
semistarved rats are associated with a signiﬁcantly
higher ratio of polyunsaturated to saturated fatty acids,
i.e., a higher PUFA:SFA ratio (P0.05).
During refeeding, in contrast, the PUFA:SFA ratio in
the PL fraction, as well as in the MG fraction, is
signiﬁcantly lower in muscles from refed animals than
in controls, and this is associated with a signiﬁcantly
higher 9 desaturation index and relative proportion
of monounsaturates than in controls (Fig. 6). In the
muscle from refed animals, the PL fraction also shows a
higher ratio of 18:1/18:0 (50%, P0.01) and a higher
relative percentage of C18:1 fatty acids (15%,
P0.05), while the MG fraction shows a higher ratio of
16:1/16:0 (64%, P0.01), a higher percentage of
C16:1 fatty acids (72%, P0.01), and a tendency for
18:1/18:0 ratio and for 18:1 to be higher than in
controls. Furthermore, although the ratio of 18:1/18:0
was not different in the DG fraction, the percentage of
C18:1 fatty acid in this fraction was also found to be
signiﬁcantly higher in muscle from refed than from
control animals (14%, P0.05). Thus, our ﬁndings of
an elevated gene expression of SCD1 (an enzyme that
catalyzes the synthesis of MUFA) during both semistar-
vation and refeeding can indeed be associated with
increased indices of 9 desaturation and/or content of
the products of SCD1 (16:1 and/or 18:1) in several
muscle lipid fractions.
DISCUSSION
In its capacity as the rate-limiting enzyme for de novo
synthesis of MUFA, SCD1 catalyzes the introduction of
Δ
Figure 4. Microsomal 9 desaturase (SCD) activity (A) and
intramyocellular lipid content (B) from skeletal muscle (tib-
ialis anterior) at the end of 2 wk of semistarvation and after 1
wk of refeeding. All values are means and se; (n6–8); *P 
0.05; **P  0.01.
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a double-bond at the 9 position of SFA, preferring
palmitoyl-CoA (C16:0) and stearoyl-CoA (C18:0) as
substrates, and producing palmitoleolyl-CoA (C16:1)
and oleoyl-CoA (C18:1), respectively. These SCD1-de-
rived MUFA, as opposed to those derived directly from
dietary sources, are substrates for the synthesis of a
variety of lipids (including phospholipids, cholesterol
esters, wax esters, triacylglycerol, and alkyldiacylglycer-
ols) that subserve a wide range of cellular and meta-
bolic functions (44). As this study was in progress, a role
for SCD1 as a negative modulator of thermogenesis was
proposed based on investigations indicating that dis-
ruption of the SCD1 gene in mice results in markedly
higher energy expenditure, which renders the animals
resistant to obesity (30, 31, 45). The studies presented
here in a rat model of semistarvation-refeeding suggest
that SCD1 in skeletal muscle may be an important
control point in the effector system of the adipose-
speciﬁc suppression of thermogenesis. First, the gene
expression of SCD1, which is elevated in skeletal muscle
after 2 wk of semistarvation, remains elevated in paral-
lel to the phase of suppressed thermogenesis that favors
catch-up fat, which lasts for at least 10 days after the
onset of refeeding. Second, these elevations in the
SCD1 transcript in skeletal muscle are associated with
elevations in SCD enzyme activity as well as in the
relative content of the SCD1-derived monounsaturates
(C16:1 and/or C18:1) in several lipid fractions ex-
tracted from skeletal muscle. Third, these elevations in
SCD1 transcript and in indices of elevated SCD1 activity
in skeletal muscle are inversely associated with levels of
hormones known for their stimulatory effects on ther-
mogenesis in skeletal muscle as well as for their poten-
tially repressive effects on SCD1 expression. Taken
together, these data underscore a role for skeletal
muscle SCD1 up-regulation in the neurohormonal ef-
fector system that suppresses thermogenesis in favor of
catch-up fat during weight recovery.
Gene search
The attribution to SCD1 of such a role in adaptive
thermogenesis derives from the screening and valida-
tion, by quantitative RT-PCR, of three sets of candidate
genes for an expression proﬁle of persistent up-regula-
tion or persistent down-regulation in skeletal muscle
during early refeeding after semistarvation, namely 1)
those genes identiﬁed for showing this pattern of
expression by the technique of differential display
followed by microarray analysis, notably genes that
code for muscle-speciﬁc proteins related to structure/
Figure 5. SCD1 desaturation index (16:1/16:0 and 18:1:18:0), relative content in monounsaturated fatty acids (C16:1, C18:1
composition), and ratio of polyunsaturated to saturated fatty acids (PUFA/SFA) in various lipid fractions of tibialis anterior
muscle harvested after 2 wk of semistarvation. All values are means and se (n6); *P  0.05; **P  0.01.
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contraction (myosins and collagen) and MEG3/GTL2,
an untranslated gene; 2) genes that are involved in
calcium cycling (SERCA1, SERCA 2a, and sarcolipin),
which are known to be regulated by thyroid hormones
and possibly by catecholamines, and selected on the
basis of literature ﬁndings that the reduction of circu-
lating T3 concentrations during food restriction per-
sists during refeeding in parallel to the recovery of
weight (7); and 3) genes the deletion or overexpression
of which, by gene manipulation technology in muscle
cell systems or in generating transgenic mice, have
been reported to result either in altered thermogenesis
(PGC-1, mitofusin2, IL6, DGAT1, and SCD1) or in an
altered gene proﬁle that is consistent with -adrenergic
control of thermogenesis (Nur77).
In the overall analysis of these data, SCD1 and
MEG3/GTL2 were the only transcripts that showed the
pattern of expression that consistently correlated with a
persistent suppression of thermogenesis directed at
catch-up fat during refeeding after semistarvation. The
SCD1 transcript showed a robust elevation in mRNA
levels of 3- to 4-fold relative to controls, both after 2 wk
of semistarvation and after 1 wk of refeeding, whereas
the MEG3/GTL2 transcript showed a down-regulation
(by 2-fold) during semistarvation and refeeding.
However, since MEG is an untranslated gene the spe-
ciﬁc function of which is unknown (40), SCD1 is the
only translated gene among those screened the pattern
of expression of which was consistently found to corre-
late with the adipose-speciﬁc control of thermogenesis.
Organ/tissue speciﬁcity
This pattern of SCD1 gene regulation is skeletal muscle
speciﬁc. In contrast to skeletal muscle where the SCD1
transcript is persistently up-regulated during the ﬁrst 10
days of refeeding after semistarvation, it is either down-
regulated or unaltered in liver and in white adipose
tissue during semistarvation and refeeding. This differ-
ential tissue regulation of SCD1 expression also sug-
gests that the observed elevation in the SCD1 transcript
in skeletal muscle is unlikely to have resulted from
contaminations with adipocytes. Furthermore, our data
indicating that 1) the gene expression of a classic
adipocyte marker like leptin (which is expressed at very
low levels in muscle) was not altered in skeletal muscle
in response to semistarvation and refeeding (Table 2);
and that 2) histological staining of neutral lipids of
muscle sections with ORO did not reveal staining in
areas other than in myocytes provide further evidence
Figure 6. SCD1 desaturation index (16:1/16:0 and 18:1:18:0), relative content in monounsaturated fatty acids (C16:1, C18:1
composition), and ratio of polyunsaturated to saturated fatty acids (PUFA/SFA) in various lipid fractions of tibialis anterior
muscle harvested after 1 wk of refeeding. All values are means and se (n6); *P  0.05; **P  0.01; ***P  0.001.
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that excludes adipocyte contaminations as a contribut-
ing factor to the observed up-regulation of SCD1 in our
skeletal muscle samples.
Indices of SCD1 activity
The functional relevance of these elevations in the
SCD1 transcript to skeletal muscle lipid metabolism
during semistarvation and refeeding is underlined by
the results of subsequent analysis of microsomal and
lipid fractions extracted from these muscles that indi-
cate parallel elevations in several indices of SCD1
activity, namely 1) an increase in the enzyme activity of
SCD in the microsomal fractions; 2) an increase in the
relative content of SCD1-derived MUFA, palmitoleolyl-
CoA (C16:1) and oleoyl-CoA (C18:1), in several lipid
fractions; and 3) an increase in the SCD1 desaturation
index that relates substrate and product in the reaction
catalyzed by SCD1 and was calculated as the ratio of
C18:1/C18:0 or C16:1/C16:0 in each lipid fraction
using the quantitated values for palmitate (16:0), palmi-
toleate (16:1), stearate (18:0), and oleate (18:1).
These data reveal similarities, but also striking differ-
ences, in the changes in skeletal muscle lipid composi-
tion during semistarvation as opposed to those ob-
served during refeeding. Whereas the elevations in
muscle SCD1-desaturation index and/or in the relative
proportion of the SCD1-derived-MUFA were found in
the MG and DG fractions both in response to semistar-
vation and to refeeding, they were only observed in the
TG fraction in response to semistarvation and only in
the PL fraction in response to refeeding. The possibility
thus arises that while both semistarvation and refeeding
increased the relative content of SCD1-derived MUFA
in the intermediates of lipid metabolism (i.e., MG and
DG), semistarvation also increased the relative content
of these monounsaturates in the storage lipids (i.e.,
TG) but not in the membrane lipids (i.e., PL), while
refeeding also increased the relative content of these
monounsaturates in the membrane lipids (i.e., PL) but
not in the storage lipids. Indeed, the changes in fatty
acid composition of the PL fraction in response to
refeeding, i.e., increases in MUFA and in SFA and
decreases in PUFA:SFA ratio, are exactly opposite to
those observed during semistarvation, i.e., decreases in
MUFA and SFA and an increase in PUFA:SFA ratio.
Given the role attributed to the fatty acid composition
of skeletal muscle PL and whole-body insulin sensitivity
(46), these differential changes in fatty acid composi-
tion of PL are consistent with our previous demonstra-
tion, in this same semistarvation-refeeding rat model,
that the shift from semistarvation to refeeding is accom-
panied by a shift from a state of increased insulin
sensitivity during semistarvation to one of diminished
insulin sensitivity and hyperinsulinemia during refeed-
ing (12). The use of euglycemic-hyperinsulinemic
clamp during refeeding has suggested that such sup-
pression of thermogenesis directed at catch-up fat is
accompanied by insulin resistance in skeletal muscle
(13), all of which precede the appearance of excess
body fat and elevations in intramyocellular lipids.
These ﬁndings, together with the data reported here
showing a persistent elevation of SCD1 and an increase
in the proportion of MUFA in phospholipids and
intermediate lipid fractions during refeeding therefore
underscore potentially important link between SCD1
up-regulation in skeletal muscle and suppressed ther-
mogenesis that spares glucose (Glc) from utilization in
skeletal muscle for the purpose of catch-up fat. They
also underscore a potentially important role for skeletal
muscle SCD1 up-regulation in the mechanisms by
which suppressed thermogenesis confers enhanced sus-
ceptibility to insulin resistance during catch-up growth
or weight recovery in adults (47), a risk factor for later
metabolic syndrome (14, 48).
Linking muscle SCD1 up-regulation to
suppressed thermogenesis
The mechanisms by which these elevations in SCD1
activity and differential ﬂux of SCD1-derived MUFA
toward stored lipids (during semistarvation) or toward
membrane lipids (during refeeding) might lead to
suppressed thermogenesis in skeletal muscle are un-
known. A common function of desaturases in organ-
isms is to maintain the physical property of stored
triglycerides and membrane lipids. One possibility
therefore is that SCD1, by regulating the fatty acid
composition of stored lipids and/or membrane phos-
pholipids (49), induces modiﬁcations in lipid-signaling
molecules and/or membrane fatty acid composition
that might alter the activities of multiple regulatory
enzymes and proteins that are involved in the cellular
effector system that mediates thermogenesis. Of partic-
ular relevance in this context are the ﬁndings that the
enhanced thermogenesis in mice lacking SCD1 can be
associated with increases in the activities of skeletal
muscle phosphatidylinositol-3 kinase (50) and AMP-
activated protein kinase (51), two signaling pathways
that have been shown to be required for hormonal
stimulation of skeletal muscle thermogenesis possibly
through their actions in orchestrating substrate cycling
between de novo lipogenesis and lipid oxidation (52–
54). An alternative explanation is based on evidence
that MUFA are much less potent than SFA as inhibitors
of acetyl-CoA carboxylase (55,56), the enzyme that
catalyzes the synthesis of malonyl CoA, the immediate
precursor for de novo synthesis of fatty acids. The
possibility therefore arises that muscle SCD1 up-regu-
lation, by increasing the conversion of de novo synthe-
sized SFA to MUFA, would lead to diminished feedback
inhibition of de novo synthesized fatty acids on the
formation of their precursor substrate malonyl CoA,
which is also an inhibitor of mitochondrial CPT1
shuttle system that controls import and oxidation of
fatty acids (including SFA and MUFA) in mitochondria.
Thus, as depicted in the schematic model presented in
Fig. 7, by enhancing the conversion of the SFA prod-
ucts of de novo lipogenesis to MUFA, an elevated SCD1
11
ht
tp
://
do
c.
re
ro
.c
h
would divert de novo synthesized SFA and its MUFA
products away from pathways of lipid -oxidation and
effectively shut down this energy-dissipating substrate
cycle, thereby leading to energy conservation. This
model takes into account the differential effects of
SCD1 up-regulation during semistarvation and refeed-
ing, namely with the SCD1-derived MUFA being chan-
neled, via the MG and DG intermediates of lipid
metabolism, toward storage lipids (TG) during semi-
starvation, as opposed to being channeled toward mem-
brane lipids (PL) during refeeding.
How these elevations in SCD1 gene transcription and
activity are induced in skeletal muscle as a function of
the size of fat stores during semistarvation and refeed-
ing is also an important issue that remains to be
addressed. It is, however, known that SCD1 gene tran-
scription and/or SCD activity are repressed by hor-
mones known to exert stimulatory effects on thermo-
genesis in skeletal muscle, namely leptin (42, 43) and
thyroid hormones (23, 43) and possibly also cat-
echolamines (16) whose second messenger cAMP has
been implicated in SCD1 repression (43). Our ﬁndings
here indicating that at least two of them are reduced
during semistarvation (leptin, T3, and T4) and during
the phase of suppressed thermogenesis that favors
catch-up fat (T3 and epinephrine) are hence consistent
with our proposal that skeletal muscle SCD1 is a key
control point in the neurohormonal effector system of
the adipose-speciﬁc control of thermogenesis.
In recent years, SCD1 has been proposed as a target
for the treatment of obesity and the metabolic syn-
drome after the demonstrations that its disruption in
mice, whether by natural mutation (30), by gene knock-
out technology (31), or by the use of speciﬁc antisense
oligonucleotides (45), leads to enhanced thermogene-
sis, which confers resistance to obesity and its comor-
bidities. Together with a recent demonstration that
SCD1 expression is up-regulated both in skeletal mus-
cle and in primary skeletal myocytes from obese hu-
mans (57), our ﬁndings here implicating a role for
skeletal muscle SCD1 up-regulation in the adaptive
suppression of thermogenesis that regulates body fat
stores have two major implications: 1) they underscore
a physiological role of SCD1 in body weight and body
composition regulation, and 2) they provide a physio-
logical rationale for targeting skeletal muscle SCD1 or
its lipid product moieties in the management of obesity
as well as in counteracting the preferential catch-up fat
phenotype that contributes to the pathophysiological
consequences of rapid catch-up growth.
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